Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH 3 Cells and Pheochromocytoma PC12 Cells

Sheng-Nan Wu, Shiuh Inn Liu, Mei Han Huang

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The effects of cilostazol, a dual inhibitor of type 3 phosphodiesterase and adenosine uptake, on ion currents were investigated in pituitary GH 3 cells and pheochromocytoma PC12 cells. In whole-cell configuration, cilostazol (10 μM) reversibly increased the amplitude of Ca 2+-activated K+ current [IK(Ca)]-Cilostazol- induced increase in IK(Ca) was suppressed by paxilline (1 μM) but not glibenclamide (10 μM), dequalinium dichloride (10 μM), or β-bungarotoxin (200 nM). Pretreatment of adenosine deaminase (1 U/ml) or α,β-methylene-ADP (100 μM) for 5 h did not alter the magnitude of cilostazol-stimulated IK(Ca). Cilostazol (30 μM) slightly suppressed voltage-dependent L-type Ca2+ current. In inside-out configuration, bath application of cilostazol (10 μM) into intracellular surface caused no change in single-channel conductance; however, it did increase the activity of large-conductance Ca2+-activated K + (BKca) channels. Cilostazol enhanced the channel activity in a concentration-dependent manner with an EC50 value of 3.5 μM. Cilostazol (10 μM) shifted the activation curve of BK Ca channels to less positive membrane potentials. Changes in the kinetic behavior of BKCa channels caused by cilostazol were related to an increase in mean open time and a decrease in mean closed time. Under current-clamp configuration, cilostazol decreased the firing frequency of action potentials. In pheochromocytoma PC12 cells, cilostazol (10 μM) also increased IK(Ca) channel activity. Cilostazol-mediated stimulation of IK(Ca) appeared to be not linked to its inhibition of adenosine uptake or phosphodiesterase. The channel-stimulating properties of cilostazol may, at least in part, contribute to the underlying mechanisms by which it affects neuroendocrine function.

Original languageEnglish
Pages (from-to)1175-1184
Number of pages10
JournalEndocrinology
Volume145
Issue number3
DOIs
Publication statusPublished - 2004 Mar 1

Fingerprint

Phosphodiesterase 3 Inhibitors
Somatotrophs
Large-Conductance Calcium-Activated Potassium Channels
PC12 Cells
Pheochromocytoma
cilostazol
Adenosine
Dequalinium
Calcium-Activated Potassium Channels
Bungarotoxins
Adenosine Deaminase
Glyburide
Phosphoric Diester Hydrolases
Baths

All Science Journal Classification (ASJC) codes

  • Endocrinology

Cite this

@article{9fd6e96b225349f6bd20a79abb3c81e2,
title = "Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH 3 Cells and Pheochromocytoma PC12 Cells",
abstract = "The effects of cilostazol, a dual inhibitor of type 3 phosphodiesterase and adenosine uptake, on ion currents were investigated in pituitary GH 3 cells and pheochromocytoma PC12 cells. In whole-cell configuration, cilostazol (10 μM) reversibly increased the amplitude of Ca 2+-activated K+ current [IK(Ca)]-Cilostazol- induced increase in IK(Ca) was suppressed by paxilline (1 μM) but not glibenclamide (10 μM), dequalinium dichloride (10 μM), or β-bungarotoxin (200 nM). Pretreatment of adenosine deaminase (1 U/ml) or α,β-methylene-ADP (100 μM) for 5 h did not alter the magnitude of cilostazol-stimulated IK(Ca). Cilostazol (30 μM) slightly suppressed voltage-dependent L-type Ca2+ current. In inside-out configuration, bath application of cilostazol (10 μM) into intracellular surface caused no change in single-channel conductance; however, it did increase the activity of large-conductance Ca2+-activated K + (BKca) channels. Cilostazol enhanced the channel activity in a concentration-dependent manner with an EC50 value of 3.5 μM. Cilostazol (10 μM) shifted the activation curve of BK Ca channels to less positive membrane potentials. Changes in the kinetic behavior of BKCa channels caused by cilostazol were related to an increase in mean open time and a decrease in mean closed time. Under current-clamp configuration, cilostazol decreased the firing frequency of action potentials. In pheochromocytoma PC12 cells, cilostazol (10 μM) also increased IK(Ca) channel activity. Cilostazol-mediated stimulation of IK(Ca) appeared to be not linked to its inhibition of adenosine uptake or phosphodiesterase. The channel-stimulating properties of cilostazol may, at least in part, contribute to the underlying mechanisms by which it affects neuroendocrine function.",
author = "Sheng-Nan Wu and Liu, {Shiuh Inn} and Huang, {Mei Han}",
year = "2004",
month = "3",
day = "1",
doi = "10.1210/en.2003-1430",
language = "English",
volume = "145",
pages = "1175--1184",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "3",

}

Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH 3 Cells and Pheochromocytoma PC12 Cells. / Wu, Sheng-Nan; Liu, Shiuh Inn; Huang, Mei Han.

In: Endocrinology, Vol. 145, No. 3, 01.03.2004, p. 1175-1184.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH 3 Cells and Pheochromocytoma PC12 Cells

AU - Wu, Sheng-Nan

AU - Liu, Shiuh Inn

AU - Huang, Mei Han

PY - 2004/3/1

Y1 - 2004/3/1

N2 - The effects of cilostazol, a dual inhibitor of type 3 phosphodiesterase and adenosine uptake, on ion currents were investigated in pituitary GH 3 cells and pheochromocytoma PC12 cells. In whole-cell configuration, cilostazol (10 μM) reversibly increased the amplitude of Ca 2+-activated K+ current [IK(Ca)]-Cilostazol- induced increase in IK(Ca) was suppressed by paxilline (1 μM) but not glibenclamide (10 μM), dequalinium dichloride (10 μM), or β-bungarotoxin (200 nM). Pretreatment of adenosine deaminase (1 U/ml) or α,β-methylene-ADP (100 μM) for 5 h did not alter the magnitude of cilostazol-stimulated IK(Ca). Cilostazol (30 μM) slightly suppressed voltage-dependent L-type Ca2+ current. In inside-out configuration, bath application of cilostazol (10 μM) into intracellular surface caused no change in single-channel conductance; however, it did increase the activity of large-conductance Ca2+-activated K + (BKca) channels. Cilostazol enhanced the channel activity in a concentration-dependent manner with an EC50 value of 3.5 μM. Cilostazol (10 μM) shifted the activation curve of BK Ca channels to less positive membrane potentials. Changes in the kinetic behavior of BKCa channels caused by cilostazol were related to an increase in mean open time and a decrease in mean closed time. Under current-clamp configuration, cilostazol decreased the firing frequency of action potentials. In pheochromocytoma PC12 cells, cilostazol (10 μM) also increased IK(Ca) channel activity. Cilostazol-mediated stimulation of IK(Ca) appeared to be not linked to its inhibition of adenosine uptake or phosphodiesterase. The channel-stimulating properties of cilostazol may, at least in part, contribute to the underlying mechanisms by which it affects neuroendocrine function.

AB - The effects of cilostazol, a dual inhibitor of type 3 phosphodiesterase and adenosine uptake, on ion currents were investigated in pituitary GH 3 cells and pheochromocytoma PC12 cells. In whole-cell configuration, cilostazol (10 μM) reversibly increased the amplitude of Ca 2+-activated K+ current [IK(Ca)]-Cilostazol- induced increase in IK(Ca) was suppressed by paxilline (1 μM) but not glibenclamide (10 μM), dequalinium dichloride (10 μM), or β-bungarotoxin (200 nM). Pretreatment of adenosine deaminase (1 U/ml) or α,β-methylene-ADP (100 μM) for 5 h did not alter the magnitude of cilostazol-stimulated IK(Ca). Cilostazol (30 μM) slightly suppressed voltage-dependent L-type Ca2+ current. In inside-out configuration, bath application of cilostazol (10 μM) into intracellular surface caused no change in single-channel conductance; however, it did increase the activity of large-conductance Ca2+-activated K + (BKca) channels. Cilostazol enhanced the channel activity in a concentration-dependent manner with an EC50 value of 3.5 μM. Cilostazol (10 μM) shifted the activation curve of BK Ca channels to less positive membrane potentials. Changes in the kinetic behavior of BKCa channels caused by cilostazol were related to an increase in mean open time and a decrease in mean closed time. Under current-clamp configuration, cilostazol decreased the firing frequency of action potentials. In pheochromocytoma PC12 cells, cilostazol (10 μM) also increased IK(Ca) channel activity. Cilostazol-mediated stimulation of IK(Ca) appeared to be not linked to its inhibition of adenosine uptake or phosphodiesterase. The channel-stimulating properties of cilostazol may, at least in part, contribute to the underlying mechanisms by which it affects neuroendocrine function.

UR - http://www.scopus.com/inward/record.url?scp=1442348158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442348158&partnerID=8YFLogxK

U2 - 10.1210/en.2003-1430

DO - 10.1210/en.2003-1430

M3 - Article

VL - 145

SP - 1175

EP - 1184

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 3

ER -